Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs
The Journal of Clinical Hypertension · 2025
DOI: 10.1111/jch.14942 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Fei Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: Extracellular Traps, Neutrophils, Hypertension, Essential Hypertension. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Gansu Science and Technology Department Project, Project of Lanzhou Science and Technology Bureau.
Abstract (Originalsprache)
Hypertension is the predominant cause of cardiovascular diseases (CVDs) globally, and essential hypertension (EH) represents a significant public health challenge due to its multifactorial etiology involving complex interactions between genetic and environmental factors. However, the pathogenesis of EH is still unclear. Hypertension is a dysregulation in the renin–angiotensin–aldosterone system and sympathetic nervous system, both regulating saline homeostasis and cardiovascular function. However, current therapeutic interventions targeting these systems have limited efficacy in approximately 40% of cases, suggesting the involvement of alternative mechanisms. Inflammation is associated with the occurrence and progression of hypertension, but the underlying mechanism remains elusive, while chronic inflammation leads to tissue damage, fibrosis, and irreversible organ dysfunction. The development and maintenance of EH are caused by endothelial dysfunction, oxidative stress, and chronic inflammation. Neutrophils are involved in both acute and chronic inflammation since they represent the primary line of defense against inflammatory insults once recruited to the inflamed site where they remove harmful impurities. The process involving the formation of neutrophil extracellular traps (NETs) is called NETosis are involved in the pathogenesis and progression of CVDs, including coronary artery disease, acute myocardial infarction, peripheral arterial disease, heart failure, and atrial fibrillation. Recent investigations demonstrated that NETs facilitate the development of hypertension; however, the precise role of NETs in hypertension remains largely elusive. Therefore, this review aims to provide an overview of the current understanding regarding the involvement of NETosis in hypertension and explore the potential therapies targeting NETs for future interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
ORCID-Profile: Fei Yu
Förderung
- National Natural Science Foundation of China
- Gansu Science and Technology Department Project
- Project of Lanzhou Science and Technology Bureau
- Cuiying Scientific and Technological Innovation Program of' Lanzhou University Second Hospital
- Gansu heart rehabilitation engineering research center
- Lanzhou University "Star of Innovation" program
- Lanzhou University Medical Postgraduate Training Innovation Development Project
Zitieren
APA
Yu, F., Chen, J., Zhang, X., Ma, Z., Wang, J., & Wu, Q. (2025). Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14942
Vancouver
Yu F, Chen J, Zhang X, Ma Z, Wang J, Wu Q. Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.14942
BibTeX
@article{Yu2025,
author = {Yu, Fei and Chen, Jianshu and Zhang, Xiaowei and Ma, Zhengke and Wang, Jingtao and Wu, Qiang},
title = {Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs},
journal = {The Journal of Clinical Hypertension},
year = {2025},
doi = {10.1111/jch.14942}
}
EUVIMED